An Extension Study of MOM-M281-004 to Evaluate the Safety, Tolerability, and Efficacy of M281 Administered to Patients With Generalized Myasthenia Gravis
An Open-label Extension Study of MOM-M281-004 to Evaluate the Safety, Tolerability, and Efficacy of M281 Administered to Patients With Generalized Myasthenia Gravis
Sponsor: Momenta Pharmaceuticals, Inc.
Terminated
Study was originally halted due to the COVID-19 pandemic. The study was later terminated prematurely as the participants will have the option to enter into an open-label extension portion of a planned future study. It was not due to safety concerns.
Other terminated trials from Momenta Pharmaceuticals, Inc.
- Immune Thrombocytopenic Purpura (ITP) · Phase PHASE1/PHASE2 · Jun 2021
- Metastatic Pancreatic Cancer · Phase PHASE1/PHASE2 · Oct 2016
More terminations from Momenta Pharmaceuticals, Inc.
This PHASE2 trial investigates Generalized Myasthenia Gravis and is currently terminated or withdrawn. Momenta Pharmaceuticals, Inc. leads this study, which shows 21 recorded versions since 2019 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
21 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jul 2023 — Jul 2024 [monthly]
Terminated PHASE2
-
Mar 2022 — Jul 2023 [monthly]
Terminated PHASE2
▶ Show 16 earlier versions
-
Dec 2021 — Mar 2022 [monthly]
Terminated PHASE2
-
Jun 2021 — Dec 2021 [monthly]
Terminated PHASE2
-
Mar 2021 — Jun 2021 [monthly]
Terminated PHASE2
Status: Suspended → Terminated
-
Jan 2021 — Mar 2021 [monthly]
Suspended PHASE2
-
Nov 2020 — Jan 2021 [monthly]
Suspended PHASE2
-
May 2020 — Nov 2020 [monthly]
Suspended PHASE2
Status: Recruiting → Suspended
-
Apr 2020 — May 2020 [monthly]
Recruiting PHASE2
-
Mar 2020 — Apr 2020 [monthly]
Recruiting PHASE2
-
Feb 2020 — Mar 2020 [monthly]
Recruiting PHASE2
-
Jan 2020 — Feb 2020 [monthly]
Recruiting PHASE2
-
Dec 2019 — Jan 2020 [monthly]
Recruiting PHASE2
-
Nov 2019 — Dec 2019 [monthly]
Recruiting PHASE2
-
Oct 2019 — Nov 2019 [monthly]
Recruiting PHASE2
-
Sep 2019 — Oct 2019 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
May 2019 — Sep 2019 [monthly]
Not Yet Recruiting PHASE2
-
Apr 2019 — May 2019 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Momenta Pharmaceuticals, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .